| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.00B | +7116.9% |
| Cost of Revenue | $5.3M | +49.6% |
| Gross Profit | $10.3M | -0.6% |
| R&D Expense | $2.5M | -2.9% |
| SG&A Expense | $18.4M | +2.3% |
| Operating Income | -$10.7M | -3.9% |
| Pre-tax Income | -$10.7M | -3.6% |
| Income Tax | $70K | -21.4% |
| Net Income | -$10.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.3M | -65.6% |
| Accounts Receivable | $1.9M | -3.3% |
| Inventory | $1.4M | +73.2% |
| Current Assets | $9.2M | -52.0% |
| Total Assets | $10.2M | -49.4% |
| Current Liabilities | $3.6M | -15.9% |
| Total Liabilities | $3.8M | -18.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.2M | -7.2% |
| Capital Expenditures | $112K | -65.8% |
| Investing Cash Flow | -$311K | +4.8% |
| Financing Cash Flow | $377K | -97.1% |
| Free Cash Flow | -$10.3M | -4.8% |
| -3.4% |
| EPS (Basic) | -$1.52 | +19.6% |
| EPS (Diluted) | -$1.52 | +19.6% |
| Stockholders' Equity |
| $6.4M |
| -58.7% |